Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke Congress 2018


On behalf of the committee, we welcome you to join the upcoming 7th International Conference on Neurological Disorders and Stroke during September 10-12, 2018 at Dublin, Ireland

Neurological scatters are sicknesses of the cerebrum, spine and the nerves that interface them. There are more than 600 infections of the sensory system, for example, cerebrum tumors, epilepsy, Parkinson's ailment and stroke and less well-known ones, for example, frontotemporal dementia.

Track 1: Neurological Disorders

Neurological disorders are disorders of central and peripheral nervous system which comprises of brain, spine and nervous system. There are more than 600 neurological diseases such as epilepsy, Alzheimer, Parkinson, brain tumors, cerebrovascular diseases including stroke, and dementia which are common. Millions of people are affected worldwide due to neurological disorders.

Track 2: Cerebrovascular Disorders

Cerebrovascular refers to blood flow in the brain. Arteries supplying oxygen to the brain are affected and bring about one of a number of cerebrovascular diseases. Most common is a stroke or mini-stroke and sometimes can be hemorrhagic stroke. Cerebrovascular diseases include carotid stenosis, vertebral stenosis and intracranial stenosis, aneurysms, and vascular malformations. Restriction in blood flow can be caused by vessel narrowing, clot formation, blockage or blood vessel rupture.

It is estimated that about 6 million deaths are due to cerebrovascular disorders. It is the second leading cause of death in the world and 6th most common cause of disability.

Track 3: Neuroradiology

Neuroradiology focuses on diagnosis and assessment for any abnormalities in brain, spine, peripheral nervous system, head and neck using neuroimaging techniques.

Neuroimaging allows visual representation of structure and function of brain and nervous system. Through neuroimaging diagnosis we can evaluate the current status and progression of neurological and neurodegenerative diseases. Neuroimaging include various techniques such as MRI, PET, and CT for diagnosis.

Track 4: Neurosurgery

Neurosurgery is a surgical specialty which deals with diagnosis and treatment of neurological diseases by performing surgery on brain, spinal cord, nervous system and extra-cranial cerebrovascular system. It is performed by a skilled neurosurgeon. There are specialized branches to special and difficult conditions. Pediatric neurosurgery treats children with operable neurological diseases. Oncologic neurosurgery deals with brain and spinal tumors surgery.

Track 5: Spine and Spinal Disorders

Spinal cord is an important part which acts as a mediator between brain and peripheral nervous system. It extends from medulla oblongata in the brain stem to lumbar region of vertebral column. The brain and spinal cord together makeup central nervous system.

Spine damage can impair the sensation and movement of the person. A neutral spine refers to the "three natural curves present in a healthy spine". Most common spinal diseases are scoliosis, spina bifida, lumbar spinal stenosis etc. spinal diseases cause back pain. A spinal tumor is a condition where an unusual growth occurs in the spinal cord.

Track 6: Neurooncology

Brain tumor refers to abnormal growth of cells within the brain. There are two types of tumors: malignant or cancerous tumors and benign tumors. Symptoms may include headaches, seizures, problem with vision, vomiting, and mental changes. The cause of brain tumors is unknown. Treatment includes combination of surgery, chemo and radiation therapy.

Neurooncology is the study of brain and spine neoplasms. Many of these are life-threatening which include astrocytoma, glioma, and brain stem tumor is the most common. Commonly used treatments are radiation therapy, chemotherapy, corticosteroids and use of neurosurgical interventions.

Track 7: Ischemic Stroke

An ischemic stroke occurs when there is sudden loss of blood flow to the brain caused by blockage of artery or a temporary loss of blood supply to one part of the brain (mini-stroke). Ischemic stroke can be caused by either thrombosis or embolism. Thrombosis is obstruction of blood flow in the blood vessel due to formation of clot. Embolism occurs when a particle which can be a broken piece of thrombus, fat, air bubble or a tumor flows in the blood and reaches brain until it gets stuck in a narrow blood vessel through which it cannot pass and restricts the blood flow. This interruption of blood flow deprives the brain of oxygen which results in irreversible brain injury and disability.

Track 8: Cerebral Hemorrhage

Cerebral hemorrhage also known as cerebral bleed is caused due to rupture of blood vessel inside the brain which causes brain damage. Localized bleeding causes pressure on surrounding tissue which kills the brain cells. Most common causes are head trauma, aneurysms, arteriovenous malformations and brain tumors. Largest risk factor is high blood pressure. Symptoms are to be assessed FAST (facial droop, arm weakness, speech difficulty, time to call emergency).

Track 9: Diagnosis and Risk factors

Diagnostic tests help us to rule out the presence of a neurological disorder, but evaluating the nervous system can be complicated as same symptoms are present in different conditions. Physicians use a variety of diagnostic techniques along with chemical and metabolic analysis to detect and treat neurological diseases. Diagnosis of central nervous system assesses motor and sensory skills, the functioning of one or more cranial nerves, hearing and speech, vision, coordination and balance, mental status, and changes in mood or behavior, among other abilities. Most common tests used to diagnose a neurological condition are CT scan, MRI, EEG, EMG, Angiogram and Lumbar puncture.

Track 10: Stroke Management

Initially stroke patient is stabilized and complete evaluation is done which includes imaging and diagnosis of stroke.

Stroke it is either treated with intravenous thrombolysis using tissue plasminogen activator or mechanical treatment to physically remove the clot. In a hemorrhagic stroke, mechanical treatment to remove blood or sometimes surgery is done.

Track 11: Surgery for Hemorrhage

Hemorrhagic stroke is a medical emergency which requires immediate treatment.  The patient is closely monitored in an intensive care unit. Surgery is recommended depending upon the stroke severity and patient’s condition. A surgery is performed to remove the hematoma and to reduce the pressure on the brain. Surgery for aneurysm is done if hemorrhage is caused by a ruptured aneurysm. Surgery is required only if the hematoma is greater than 3cm and if there is any vascular lesion in young patients.

Track 12: Stroke Rehabilitation

Rehabilitation is an important phase for patients after stroke. Stroke rehabilitation helps you to relearn skills that you lost when stroke affected a part of your brain. The goal is to help you return to independent living. Rehabilitation program depends on the severity of stroke and the part of the body affected. Stroke therapy involves: mobility and motor skills training, self-care skills, communication skills, cognitive skills such as memory and technology assisted physical activities.

Track 13: Role of Immune System in Stroke/Brain Injury

Immune reactions have an important role in stroke and are associated in the primary and secondary progression of ischemic lesions, and are also in involved in repair, recovery, and overall outcome of stroke. Immune system actively participates in the acute pathogenesis of stroke. Thrombosis and hypoxia trigger an intravascular inflammatory cascade, which is further augmented by the innate immune response to cellular damage occurring in the parenchyma. This immune activation may cause secondary tissue injury. Further research is required to determine what role does immune system has in long-term outcomes after stroke, but elucidation of potential mechanisms may open promising avenues for the development of new therapeutics to improve neurological recovery after brain injury.

Track 14: Neurology and Nursing

It is a subspecialty of nursing that helps patients suffering from neurological problems, which include injuries to brain and spine caused from accidents or illnesses. Neuroscience nurses also work with patients suffering from strokes and neurological disorders which affect their movement and cognitive ability. Their role is to assess, diagnose and treat patients that are suffering from neurological problems and also perform thorough physical examinations of patients. They may also help in administering medications or even assist during surgery.

Track 15: Neuropharmacology

Neuropharmacology is the study of how drug affects the cellular function in the neural system. There are mainly 2 types: behavioral and molecular neuropharmacology. Behavioral neuropharmacology refers to study of how drug affects human behavior which includes drug dependence and also how addiction affects the brain. Molecular neuropharmacology involves study of neurons and their neural mechanisms which affect the behavior. Neuropharmacology helps in developing drugs that benefits neurological function and helps us to better understand the basis for new drug development.

Track 16: Neuropsychiatry and Mental Health

Neuropsychiatry is a sub-specialty of psychiatry which understands the link between mind, body and its behavior. It is the interface of psychiatry and neurology that deals with mental disorders that attribute to neurological disorders. Neuropsychiatry addresses cognition and/or behavior problems caused by brain injury or brain disease. Neuropsychiatrist is trained in both neurological and psychiatric aspects of illness, which helps them to give exclusive care.

Track 17: Clinical Trials and Case Reports

Worldwide millions of people are suffering from neurological diseases and annually around 6 million people are dying due to various neurological diseases. There are more than 600 known neurological diseases which affect our nervous system but there are limited treatment options till date and there is ongoing research.

Clinical trials and case reports in various fields such as neurooncology, neurosurgery, and stroke recovery are present for the scientists, researchers and doctors to share their experiences of new and complicated neurological conditions. This track gives researchers knowledge about new technologies, clinical trials and new aspects.

Track 18: Therapeutic Approaches for Neurological Disorders

Some of the approaches such as neural stem cell technique and deep brain stimulation are being advantageous in the treatment of neurological disorders. This conference provides a platform for the researchers to discuss and learn about new therapeutics evolved for neurological disorders.

About Conference

On behalf of Conference Series Ltd, we welcome the participants from all over the world to attend the Neurology conference entitled “7th International Conference on Neurological Disorders and Stroke” to be held during September 10-12, 2018  at Dublin, Ireland.

Stroke Congress 2018 is organized around the theme “An Insight into advanced research on diagnosis and treatment of neurological disorders and stroke”.

The aim of Stroke Congress 2018 is to provide a platform for exchange of ideas and to share their state of art research and technologies of scientists which would cover the wide range of critically important sessions of neurological disorders and stroke.

Stroke Congress 2018 is an annual meeting of Neurology committees and stroke associations to discuss the future of Neurological disorders and stroke in terms of collaboration, structures and organizational development and advances of treatment.

Why to attend?

7th International Conference on Neurological Disorders and Stroke is a unique forum to bring together worldwide recognized scholastics in the field of neuroscience, brain researchers, public health experts, academic scientists, industry specialists to trade about advanced research and innovations.

The goal of the conference is to initiate new ideas for treatment that will be beneficial across the spectrum of neurological disorders.


Target Audience

Neuroscientists, Neurosurgeons, Pediatric neurosurgeons, Neuroradiologists, Stroke researchers, Neuro Oncologists, Business delegates, Stroke rehabilitation experts, CEO's and R&D Heads from Industries, Directors, Neuroscience nurses, Neuropsychiatrists, Professors and Students and all researchers in the field of Neurology.

Market Analysis

       According to World Health Organization neurological disorders included in the neuropsychiatric category contribute to 2% of the global burden of disease, while cerebrovascular disease and some of the neuroinfections (poliomyelitis, tetanus, meningitis and Japanese encephalitis) contribute to 4.3% of the global burden of disease in 2005. Thus neurological disorders constitute 6.3% of the global burden of disease. Neurological disorders attribute to 92 million disability-adjusted life years (DALYs) in 2005 projected to increase to 103 million in 2030 (approximately a 12% increase). Alzheimer and other dementias are projected to show a 66% increase from 2005 to 2030. Neurological disorders are an important cause of mortality and constitute 12% of total deaths globally. Among these, cerebrovascular diseases are responsible for 85% of the deaths.

       The global market for neurological disease treatment and medication was worth $12.6 billion in 2006 and will reach $14 billion by 2007. At a compound annual growth rate (CAGR) of 11.6%, the global market will be worth almost $24.3 billion by 2012. Drugs for multiple sclerosis, Alzheimer's disease, and Parkinson's disease control approximately 99% of the total market share.

         Europe Neurological Disorder Drugs Market is expected to reach US$32.0 Billion by 2024.  During the forecast period of 2016 and 2024, the global market is projected to expand at CAGR of 6.4%. The Europe neurological disorder drug market involves wide range of diseases. But the analysts assume that the cerebrovascular disease segment will progress at a CAGR of 6.9% during the forecast period. On the basis of countries, the market is divided into Germany, France, Italy, Spain, UK, Russia, Switzerland, Netherlands, Poland, and Rest of Europe.

The scope of the conference includes novel therapeutics and neuro-immune interactions. This conference goal is to talk about relevant topics in neuroscience and the scientists and professionals to share their knowledge and experience in the field of neuroscience.

Past Conference Report

Stroke 2017

International Conference on Neurological Disorders & Stroke and Neurooncology  was organized during April 24-25, 2017 at Dubai, UAE with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Stroke 2017, a global platform to discuss various important aspects of Neurology.

The conference was organized around the theme “Adaptive treatments and Modern Diagnosis for Neurological Disorders and Stroke”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  Sandro Iannaccone, San Raffaele hospital, Milan Italy, Josh Underwood, Vermont Academy, USA, Wai Kwong Tang, Chinese University of Hong Kong, and Rola Aatif Mahmood, Slamaniya Medicals, Bahrain.

So as a continuation of Stroke 2017, we would like to heartily invite you to our upcoming 5th Interna­tional Conference on Neurological Disorders and Stroke scheduled during November 13-14, 2017 at London, UK. We look forward to see your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming

7th Interna­tional Conference on Neurological Disorders and Stroke

September 10-12, 2018 at Dublin, Ireland


Stroke 2016

2nd International Conference on Neurological Disorders and Stroke was organized during April 28-30, 2016 at The Hotel Oberoi Dubai, UAE with the support and contribution of the Organizing Committee Members.

All the participants was awarded with 19.75 AMA PRA Category 1 CreditsTM

There are infinite reasons to extend our gratitude to you for making the Stroke 2016 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Stroke 2016 a new heights in the field of Neuroscience.

The conference was organized around the theme “Novel approaches and Developments in Neurological disorders and Stroke”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  Mohamad Fayez Al Homsi, University of Sharjah, UAE, Shireen Qureshi, Johns Hopkins Aramco Healthcare, Saudi Arabia, Yusuf Al-bustanji, United Arab Emirate University, UAE, and Hosam Al-Jehani, Dammam University, Saudi Arabia

Workshop was conducted on Advanced Homecare-Prothrombin Time (INR) Testing in a Home Setting by Michael Redmond, AMANA Healthcare Medical and Rehabilitation Hospital-Al Ain, UAE.


Stroke 2015

Global Summit on Stroke was organized during August 03-05, 2015 at Birmingham, UK with the support and contribution of the Organizing Committee Members.

The conference was organized around the theme “Developing trends and new advances in stroke treatment & prevention”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological disorders and Stroke through their fabulous presentations at the podium of Stroke 2015. 

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  Howard Prentice, Florida Atlantic University, USA, Xin Wang, Harvard Medical School, USA, Stefan Golaszewski, Paracelsus Medical University Salzburg, Austria, and Saema Ansar, Lund University, Sweden.

To Collaborate Scientific Professionals around the World

Conference Date September 10-12, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurological Disorders Brain Disorders & Therapy International Journal of Neurorehabilitation

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos